Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Falk

Showing results (491-500 of 537) with videos related to

Pageof 54
Sort By:
American Heart Journal|August 11, 2012
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)Frederick L Ruberg, Mathew S Maurer, Daniel P Judge, et al.
The Journal of General Virology|April 11, 2006
Relationship between retroviral vector membrane and vector stabilityM Carmo, T Q Faria, H Falk, et al.
Clinical Lymphoma|April 4, 2003
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosisDavid C Seldin, Elie B Choufani, Laura M Dember, et al.
JAMA Cardiology|July 27, 2018
Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac AmyloidosisKevin M Alexander, John Orav, Avinainder Singh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Absolute Quantitation of Cardiac <sup>99m</sup>Tc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CTSharmila Dorbala, Mi-Ae Park, Sarah Cuddy, et al.
European Journal of Heart Failure|April 30, 2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African AmericansMasatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
JACC. Cardiovascular Imaging|December 15, 2023
Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid CardiomyopathyLouhai Alwan, Dominik C Benz, Sarah A M Cuddy, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
JAMA Cardiology|March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO StudyMasatoshi Minamisawa, Brian Claggett, David Adams, et al.
Journal of Neural Engineering|May 20, 2014
Performance measurement for brain-computer or brain-machine interfaces: a tutorialDavid E Thompson, Lucia R Quitadamo, Luca Mainardi, et al.
Pageof 54

Showing results (491-500 of 537) with videos related to

Sort By:
Pageof 54
American Heart Journal|August 11, 2012
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)Frederick L Ruberg, Mathew S Maurer, Daniel P Judge, et al.
The Journal of General Virology|April 11, 2006
Relationship between retroviral vector membrane and vector stabilityM Carmo, T Q Faria, H Falk, et al.
Clinical Lymphoma|April 4, 2003
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosisDavid C Seldin, Elie B Choufani, Laura M Dember, et al.
JAMA Cardiology|July 27, 2018
Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac AmyloidosisKevin M Alexander, John Orav, Avinainder Singh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Absolute Quantitation of Cardiac <sup>99m</sup>Tc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CTSharmila Dorbala, Mi-Ae Park, Sarah Cuddy, et al.
European Journal of Heart Failure|April 30, 2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African AmericansMasatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
JACC. Cardiovascular Imaging|December 15, 2023
Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid CardiomyopathyLouhai Alwan, Dominik C Benz, Sarah A M Cuddy, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
JAMA Cardiology|March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO StudyMasatoshi Minamisawa, Brian Claggett, David Adams, et al.
Journal of Neural Engineering|May 20, 2014
Performance measurement for brain-computer or brain-machine interfaces: a tutorialDavid E Thompson, Lucia R Quitadamo, Luca Mainardi, et al.
Pageof 54